IDDST-2023
Abstract Information

The IDDST-2023 Scientific Committee is inviting the submission of scientific abstracts for proffered paper and poster sessions.

Authors are asked to submit abstracts under one of the following categories, but not limited:

ADME Tox

HTS

Biochemistry

Imaging

Biopharmaceuticals

Immunology

Cancer Biology

Lead Discovery & Profiling

Cardiology

Medicinal Chemistry

Cell Biology

Microbiology

Cellular Hit Identification

Molecular Pharmacology

Chemistry

Oncology

Clinical Development

Pharmacokinetics

Clinical Pharmacology

R&D

Clinical R&D

Structural Biochemistry

DMPK

Target Discovery

Drug Discovery & Development

Toxicology

Drug Safety & Metabolism

Translational Sciences

Enabling Technologies

Virology


Abstracts must be in English and contain a maximum of 2800 characters with space in Microsoft Word. A data table may be included where required, but will count as 600 characters against the 2800 characters total. A maximum of 1 image file may also be included, but each image will count as 600 characters against the 2800 characters total. All abstracts accepted by the Scientific Committee will be published in the conference proceeding. The Scientific Committee will review all submitted abstracts, and will determine if an abstract is to be presented orally, by poster, or by publication only.

Abstracts failing to meet minimum standards or are not relevant to this conference will be declined. Authors may submit multiple abstracts, but usually an individual will not be offered more than one oral presentation.

© 2003-2023 All rights reserved by BITeomics
Contact Us: Tel:0086-411-84799609,Email:Irene@iddst.com
备案号:辽ICP备08007502号